To assess the efficacy and safety of latanoprostene bunod ( LBN ) compared with latanoprost 0.005 % , and to determine the optimum drug concentration ( s ) of LBN in reducing intraocular pressure ( IOP ) in subjects with open angle glaucoma or ocular hypertension .